## CTVA: Corteva, Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 -2.5% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($62.78)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Global Retirement Partners LLC Makes New Investment in Corteva, Inc. $CTVA**
- Source: MarketBeat | 20251201T101050 | Bullish | Relevance: 99%
- Global Retirement Partners LLC has acquired a new stake of 4,645 shares in Corteva, Inc. (NYSE:CTVA) valued at approximately $346,000, as institutional ownership of the stock reaches 81.54%. Corteva reported strong financial results, beating EPS and revenue estimates, and declared a quarterly dividend of $0.18. Analyst consensus is a "Moderate Buy" with a price target of $78.05.

**2. Corteva insider stock sales raise questions as company posts December dividend**
- Source: Midland Daily News | 20251202T230619 | Neutral | Relevance: 99%
- A series of insider stock sales at Corteva, Inc. over the past year is prompting fresh scrutiny for the company. Corteva may separate its seed and pesticide businesses, aligning with a 2025 breakup trend, with shares rising 1.6% after-hours. The company has also posted its December dividend.

**3. Corteva, Inc. $CTVA Shares Sold by Hsbc Holdings PLC**
- Source: MarketBeat | 20251201T120624 | Somewhat-Bullish | Relevance: 98%
-  Hsbc Holdings PLC decreased its stake in Corteva, Inc. by 5.2% during the second quarter, selling 60,277 shares and now owning 1,101,571 shares valued at approximately $82.09 million. Corteva exceeded earnings expectations for the quarter, reporting an EPS of -$0.23 against an expected -$0.49, and announced a quarterly dividend of $0.18 per share. The company currently holds a consensus "Moderate Buy" rating from analysts with an average price target of $78.05.

**4. Corteva insider stock sales raise questions as company posts December dividend**
- Source: www.theheraldreview.com | 20251202T213650 | Neutral | Relevance: 98%
- A series of insider stock sales totaling $6.9 million at Corteva, Inc. over the past year has raised concerns among shareholders, despite the company's strong third-quarter earnings report and a positive Wall Street outlook. The largest sale was by CEO Charles Magro, who unloaded $3 million worth of shares. Meanwhile, Corteva plans to split into two publicly traded companies in 2026, and recently announced a quarterly dividend.

**5. Mackenzie Financial Corp Increases Stock Holdings in Corteva, Inc. $CTVA**
- Source: MarketBeat | 20251202T114654 | Bullish | Relevance: 98%
- Mackenzie Financial Corp increased its stake in Corteva, Inc. (NYSE:CTVA) by 14.1% in Q2 2025, bringing its total holdings to 551,673 shares valued at approximately $41.12 million. Other institutional investors like Norges Bank and Neuberger Berman Group LLC also adjusted their positions, with institutional investors collectively owning 81.54% of the company's stock. Corteva reported better-than-expected Q2 earnings and revenue, announced a $0.18 quarterly dividend, and holds a "Moderate Buy" consensus rating with a target price of $78.05.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-11 | Wells Fargo | $77 | $80 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-11 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.04M) |
| Sells | 1 ($0.47M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.0%)
- Blackrock Inc.: 8.4% (+12.7%)
- State Street Corpora: 5.2% (+3.6%)
- Capital World Invest: 3.4% (+0.1%)
- FMR, LLC: 3.4% (+67.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.85 indicates undervaluation relative to growth. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $44.2B |
| Beta | 0.74 |
| 52W Range | $53.40 - $77.41 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.85 |
| Forward P/E | 22.1 |
| Current P/E | 19.7 |
| YoY Growth | -11.0% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from -0.3% to -2.5% (-2.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.5pp (needs >3.0% for momentum thesis). Below SMA200 (0.98x), long-term trend not supportive. RSI neutral at 52.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.52% (CS: 28) | Weak |
| RSI_14 | 52.2 | Neutral |
| MACD Histogram | 0.18 | Bullish |
| vs SMA20 | 1.006x | Above |
| vs SMA50 | 1.019x | Above |
| vs SMA200 | 0.977x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $65.60
- **Stop Loss:** $62.78 (4.3% risk)
- **Target:** $68.42 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 354
- **Position Value:** $23,222.40
- **Portfolio %:** 23.22%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-04 (Est: $0.21)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.47 | $-0.23 | +50.6% |
| 2025Q2 | $1.88 | $2.20 | +17.1% |
| 2025Q1 | $0.88 | $1.13 | +28.2% |
| 2024Q4 | $0.31 | $0.32 | +2.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*